• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在贝敦氏病小鼠模型中,小脑颗粒细胞对AMPA受体介导的兴奋性毒性的选择性敏感性增加。

Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease.

作者信息

Kovács Attila D, Weimer Jill M, Pearce David A

机构信息

Center for Aging and Developmental Biology, Aab Institute of Biomedical Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.

出版信息

Neurobiol Dis. 2006 Jun;22(3):575-85. doi: 10.1016/j.nbd.2005.12.018. Epub 2006 Feb 17.

DOI:10.1016/j.nbd.2005.12.018
PMID:16483786
Abstract

Batten disease, a lysosomal storage disorder, is caused by mutations in the CLN3 gene. The Cln3-knockout (Cln3-/-) mouse model of the disease exhibits many characteristic pathological features of the human disorder. Here, we show that Cln3-/- mice, similarly to Batten disease patients, have a deficit in cerebellar motor coordination. To explore the possible cellular cause of this functional impairment, we compared the vulnerability of wild type (WT) and Cln3-/- cerebellar granule cell cultures to different toxic insults. We have found that cultured Cln3-/- cerebellar granule cells are selectively more vulnerable to AMPA-type glutamate receptor-mediated toxicity than their WT counterparts. This selective sensitivity was also observed in organotypic cerebellar slice cultures. Our results suggest that lack of the CLN3 protein has a significant influence on the function of AMPA receptors in cerebellar granule neurons, and that AMPA receptor dysregulation may be a major contributor to the cerebellar dysfunction in Batten disease.

摘要

巴滕病是一种溶酶体贮积症,由CLN3基因突变引起。该疾病的Cln3基因敲除(Cln3-/-)小鼠模型表现出人类疾病的许多特征性病理特征。在此,我们表明,与巴滕病患者一样,Cln3-/-小鼠存在小脑运动协调缺陷。为了探究这种功能障碍可能的细胞原因,我们比较了野生型(WT)和Cln3-/-小脑颗粒细胞培养物对不同毒性损伤的易感性。我们发现,培养的Cln3-/-小脑颗粒细胞比野生型细胞对AMPA型谷氨酸受体介导的毒性更具选择性易感性。在小脑器官型切片培养物中也观察到了这种选择性敏感性。我们的结果表明,CLN3蛋白的缺失对小脑颗粒神经元中AMPA受体的功能有重大影响,并且AMPA受体失调可能是巴滕病小脑功能障碍的主要原因。

相似文献

1
Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease.在贝敦氏病小鼠模型中,小脑颗粒细胞对AMPA受体介导的兴奋性毒性的选择性敏感性增加。
Neurobiol Dis. 2006 Jun;22(3):575-85. doi: 10.1016/j.nbd.2005.12.018. Epub 2006 Feb 17.
2
Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.在 Cln3(Δex7/8)-敲入小鼠模型的少年神经元蜡样脂褐质沉积症中,小脑颗粒细胞对谷氨酸受体过度激活的敏感性发生改变。
Neurochem Int. 2011 May;58(6):648-55. doi: 10.1016/j.neuint.2011.02.003. Epub 2011 Feb 17.
3
Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease.在幼年脑腱黄瘤病的小鼠模型中,小脑短期可塑性改变,但突触后 AMPA 型谷氨酸受体无变化。
eNeuro. 2018 May 17;5(2). doi: 10.1523/ENEURO.0387-17.2018. eCollection 2018 Mar-Apr.
4
Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease.AMPA受体活性的减弱改善了幼年型巴滕病小鼠模型的运动技能。
Exp Neurol. 2008 Jan;209(1):288-91. doi: 10.1016/j.expneurol.2007.09.012. Epub 2007 Oct 25.
5
Abnormally increased surface expression of AMPA receptors in the cerebellum, cortex and striatum of Cln3(-/-) mice.Cln3(-/-)小鼠的小脑、皮层和纹状体中AMPA受体的表面表达异常增加。
Neurosci Lett. 2015 Oct 21;607:29-34. doi: 10.1016/j.neulet.2015.09.012. Epub 2015 Sep 12.
6
Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.幼年型神经元蜡样脂褐质沉积症小鼠模型中的小脑缺陷
Brain Res. 2009 Apr 17;1266:93-107. doi: 10.1016/j.brainres.2009.02.009. Epub 2009 Feb 20.
7
Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.年龄依赖性美金刚在幼年型神经鞘脂贮积症小鼠模型中的治疗效果。
Neuropharmacology. 2012 Oct;63(5):769-75. doi: 10.1016/j.neuropharm.2012.05.040. Epub 2012 Jun 6.
8
Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease.AMPA 受体的暂时抑制可诱导幼年型神经纤维瘤病小鼠模型运动性能的长期改善。
Neuropharmacology. 2011 Feb-Mar;60(2-3):405-9. doi: 10.1016/j.neuropharm.2010.10.010. Epub 2010 Oct 29.
9
Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.少年型贝敦氏病Cln3-/-小鼠模型中枢神经系统(CNS)中精氨酸代谢的改变
Neuropathol Appl Neurobiol. 2009 Apr;35(2):189-207. doi: 10.1111/j.1365-2990.2008.00984.x.
10
Altered gene expression in the eye of a mouse model for batten disease.巴滕病小鼠模型眼睛中的基因表达改变。
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905. doi: 10.1167/iovs.04-0143.

引用本文的文献

1
Aging, Neurodegenerative Disorders, and Cerebellum.衰老、神经退行性疾病与小脑。
Int J Mol Sci. 2024 Jan 13;25(2):1018. doi: 10.3390/ijms25021018.
2
The involvement of Purkinje cells in progressive myoclonic epilepsy: Focus on neuronal ceroid lipofuscinosis.浦肯野细胞在进行性肌阵挛性癫痫中的作用:关注神经元蜡样质脂褐质沉积症。
Neurobiol Dis. 2023 Sep;185:106258. doi: 10.1016/j.nbd.2023.106258. Epub 2023 Aug 11.
3
A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes.一种新型 CLN3 脑腱黄瘤病猪模型重现临床表型。
Dis Model Mech. 2023 Aug 1;16(8). doi: 10.1242/dmm.050038. Epub 2023 Aug 7.
4
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease.出生后早期给予AAV9基因疗法对CLN3病是安全有效的。
Front Genet. 2023 Mar 24;14:1118649. doi: 10.3389/fgene.2023.1118649. eCollection 2023.
5
Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons.溶酶体改变和 CLN3 病患者来源的皮质神经元电生理活性降低。
Dis Model Mech. 2022 Dec 1;15(12). doi: 10.1242/dmm.049651. Epub 2022 Dec 13.
6
Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype.他莫昔芬的再利用改善了 CLN3 和 CLN7 疾病表型。
EMBO Mol Med. 2021 Oct 7;13(10):e13742. doi: 10.15252/emmm.202013742. Epub 2021 Aug 19.
7
Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.神经元蜡样脂褐质沉积症的治疗进展
Expert Opin Orphan Drugs. 2019;7(11):473-500. doi: 10.1080/21678707.2019.1684258. Epub 2019 Nov 27.
8
Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.调控 Kv4.2/KChIP3 相互作用的神经蜡样脂褐质沉积症蛋白 3(CLN3)。
J Biol Chem. 2020 Aug 21;295(34):12099-12110. doi: 10.1074/jbc.RA120.013828. Epub 2020 Jul 7.
9
Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors.离子型谷氨酸受体与癫痫:聚焦 AMPA 和 NMDA 受体的综述。
Biomolecules. 2020 Mar 18;10(3):464. doi: 10.3390/biom10030464.
10
Cellular models of Batten disease.Batten 病的细胞模型。
Biochim Biophys Acta Mol Basis Dis. 2020 Sep 1;1866(9):165559. doi: 10.1016/j.bbadis.2019.165559. Epub 2019 Oct 23.